Detalhe da pesquisa
1.
Personalized therapy guided by single-cell transcriptomic analysis in relapsed and refractory KMT2A::MLLT10 AML with extensive extramedullary infiltration: A case report.
Br J Haematol;
2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38740515
2.
Preclinical testing of CT1113, a novel USP28 inhibitor, for the treatment of T-cell acute lymphoblastic leukaemia.
Br J Haematol;
204(6): 2301-2318, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38685813
3.
Chemo-free treatment of adult patients with Ph-positive acute lymphoblastic leukemia: latest updates from the 2023 ASH annual meeting.
J Hematol Oncol;
17(1): 18, 2024 04 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38627786
4.
A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens.
Hematology;
29(1): 2335856, 2024 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38581291
5.
Venetoclax plus daunorubicin and cytarabine in newly diagnosed acute myeloid leukemia patients: A propensity score-matched analysis.
Hematol Oncol;
42(2): e3260, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38415873
6.
Cellular hierarchy insights reveal leukemic stem-like cells and early death risk in acute promyelocytic leukemia.
Nat Commun;
15(1): 1423, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365836
7.
A combinatorial therapeutic approach to enhance FLT3-ITD AML treatment.
Cell Rep Med;
4(11): 101286, 2023 11 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951217
8.
Dasatinib plus prednisone as induction and consolidation for adults with Ph-positive acute lymphoblastic leukaemia: A single-arm, multicentre, phase 2 trial.
Br J Haematol;
202(6): 1119-1126, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434414
9.
A geotechnical perspective on soil-termite interaction: Role of termites in unsaturated soil properties.
Sci Total Environ;
895: 164864, 2023 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37331385
10.
CAG (cytarabine, aclarubicin and granulocyte colony-stimulating factor) regimen for core binding factor acute myeloid leukaemia with measurable residual disease.
Ann Hematol;
102(7): 1731-1738, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37145324
11.
Venetoclax plus '2 + 5' modified intensive chemotherapy with daunorubicin and cytarabine in fit elderly patients with untreated de novo acute myeloid leukaemia: a single-centre retrospective analysis.
Br J Haematol;
201(3): 568-572, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36863709
12.
Chemotherapy with the use of next-generation tyrosine kinase inhibitors based on measurable residual disease has the potential to avoid hematopoietic stem cell transplantation in treatment for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Cancer;
129(10): 1523-1536, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882308
13.
AMLnet, A deep-learning pipeline for the differential diagnosis of acute myeloid leukemia from bone marrow smears.
J Hematol Oncol;
16(1): 27, 2023 03 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36945063
14.
Targeted treatment of T-cell acute lymphoblastic leukemia: latest updates from the 2022 ASH Annual Meeting.
Exp Hematol Oncol;
12(1): 30, 2023 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36906578
15.
Targeting HDAC3 to overcome the resistance to ATRA or arsenic in acute promyelocytic leukemia through ubiquitination and degradation of PML-RARα.
Cell Death Differ;
30(5): 1320-1333, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36894687
16.
Venetoclax and blinatumomab based chemotherapy-free treatment in a patient with Philadelphia chromosome-negative acute lymphoblastic leukemia.
Ann Hematol;
102(5): 1275-1277, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36892592
17.
The clinical impact of IKZF1 mutation in acute myeloid leukemia.
Exp Hematol Oncol;
12(1): 33, 2023 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36997950
18.
A global study for acute myeloid leukemia with RARG rearrangement.
Blood Adv;
7(13): 2972-2982, 2023 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36799929
19.
At What Point Are Long-Term (>5 Years) Survivors of APL Safe? A Study from the SEER Database.
Cancers (Basel);
15(3)2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36765533
20.
Ruxolitinib combined with dexamethasone in adult patients with newly diagnosed Hemophagocytic lymphohistiocytosis: A single-center pilot trial.
Am J Hematol;
98(5): E106-E109, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789563